Moving Beyond COVID With mRNA Technology
After playing a critical role in developing new vaccine technology to help manage the COVID-19 pandemic, all eyes are on mRNA and its massive potential in various other applications. At the 2023 JP Morgan Healthcare Conference, the Penn Center for Innovation held a panel with three industry professionals with close ties to mRNA technology to discuss the future of the technology and its unfettered potential in a rapidly evolving environment.
The panel, titled “The Future of mRNA Technology,” included the co-discoverer of mRNA technology and fundamental figure in developing Pfizer and BioNTech’s COVID-19 vaccine, Katalin Kariko, Ph.D. Michael J. Mitchell, Ph.D., a drug delivery expert who worked alongside Moderna co-founder Robert Langer, also joined the panel. The third panel member was passionate scientist Laura Shawver, Ph.D., who is currently the CEO of a Penn State spinout company, Capstan Therapeutics. Renowned industry expert and Founding Managing Director of Westlake Village Partners, Beth Seidenberg, MD, moderated the panel.
The panel, titled “The Future of mRNA Technology,” included the co-discoverer of mRNA technology and fundamental figure in developing Pfizer and BioNTech’s COVID-19 vaccine, Katalin Kariko, Ph.D. Michael J. Mitchell, Ph.D., a drug delivery expert who worked alongside Moderna co-founder Robert Langer, also joined the panel. The third panel member was passionate scientist Laura Shawver, Ph.D., who is currently the CEO of a Penn State spinout company, Capstan Therapeutics. Renowned industry expert and Founding Managing Director of Westlake Village Partners, Beth Seidenberg, MD, moderated the panel.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115